Skip to content
Dentylis

Dentylis

Healthcare·France·Active·3yr hold
Entry
2023
Hold
3yr
Status
Active

Who owns Dentylis?

Dentylis is currently owned by MBO+ through MBO+ Buyout VI (2022 vintage), since 2023.

Hand-verified · updated 2026-05-10

MBO+
Investor
MBO+
MBO+ Buyout VI · 2022 · Buyout

Key facts

HQFrance
SectorHealthcare
StatusActive
Track Dentylis

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

About Dentylis

Dentylis is a Paris-based healthcare company that operates a network of conventional dental and medical centers across metropolitan France. Founded on a dental-care model, it has broadened into multi-disciplinary primary care, adding ophthalmology through its Ophtalys brand in 2019 and allergology through Allergolys in 2022, alongside dermatology, general medicine, cardiology, gynecology, midwifery and radiology. The group runs roughly 60 centers concentrated in Paris and the Ile-de-France region and extending into Provence-Alpes-Cote d'Azur, Auvergne-Rhone-Alpes, Grand-Est, Hauts-de-France, Occitanie and Nouvelle-Aquitaine. It positions itself on accessibility, applying sector 1 conventional pricing with no fee overages and practicing third-party billing with social security and mutual insurers. Industry press describes it as one of the largest dental care networks in France.

Ownership journey

Dentylis was founded in Paris in 2013 by dentist Jean-Jacques Israel, building a network of care centers priced within France's conventional sector 1 framework. In 2023 MBO Plus backed the company through its MBO Plus Buyout VI fund, taking a majority position to support an external growth and consolidation strategy in a rapidly financializing dental and primary-care market. MBO Plus remains an active shareholder and Dentylis is still listed among its current portfolio companies, with no exit or secondary transaction recorded. The MBO Plus deal team associated with the investment includes Alexandre Chaton, Chloe Miller and Zoe Tournilhac.

Under PE ownership

Since the MBO Plus investment in 2023, Dentylis has pursued the external growth strategy the buyout was designed to fund, extending its network toward roughly 60 centers across Paris, the Ile-de-France and several regions. According to MBO Plus, the company has delivered strong growth since the partnership began, supported by a dynamic market and the solid performance of its established centers. It operates a multi-specialty model spanning dentistry, ophthalmology under the Ophtalys brand, allergology, general medicine and further specialties, all within France's conventional sector 1 pricing. That build-out reflects a structural shift of dental and primary care away from independent liberal practice toward organized center networks, a trend the sponsor's consolidation thesis explicitly targets.

Who could buy Dentylis?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Dentylis.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue